Corbus Pharmaceuticals
CRBP | NASDAQ
$3.38
-$0.01 (-0.29%)
At close: Nov 16, 2026, 4:00 PM ET
$3.19
-$0.19 (-5.62%)
After-hours:
Nov 16, 2026, 7:39 PM ET
Corbus Pharmaceuticals Company Profile
Company profile explainedCompany Profile
Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.
Key Executives
| Name | Position |
|---|---|
| Yuval Cohen | Chief Executive Officer & Director |
| Ian Hodgson | Chief Operating Officer |
| Sean F. Moran | Chief Financial Officer |
| Christina Bertsch | Vice President of Human Resources |
| G. Scott Goeken | General Counsel & Corporate Secretary |
| Leonardo Viana Nicacio | Chief Medical Officer |
| Nishant C. Saxena | Chief Business Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 29, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Oct 15, 2026 | 8-K | Current Report |
| Sep 30, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Sep 15, 2026 | 4 | Filing |
| Sep 14, 2026 | 8-K | Current Report |
| Aug 17, 2026 | 4 | Filing |
| Aug 12, 2026 | 4 | Filing |
| Aug 10, 2026 | 4 | Filing |
| Aug 10, 2026 | 4 | Filing |
| Aug 07, 2026 | 424B5 | Filing |
Corbus Pharmaceuticals
| Country | United States |
| IPO Date | Oct 27, 2014 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 36 |
| CEO | Yuval Cohen |
Contact Details
500 River Ridge Drive Norwood,
Massachusetts 02062 United States
Stock Details
| Ticker Symbol | CRBP |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001595097 |
| CUSIP Number | 21833P301 |
| ISIN Number | US21833P3010 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove CRBP